Your guide to Pharmacy Law and Ethics
Guidance on ensuring safe dispensing practices, covering labelling, error prevention, and compliance with SOPs and legal standards.
Forged or fraudulent prescriptions present a serious legal and patient safety risk. Pharmacists must be able to recognise potential forgeries, understand the legal implications, and know how to respond appropriately.
Forgery of a prescription is generally prosecuted under the Forgery and Counterfeiting Act 1981:
https://www.legislation.gov.uk/ukpga/1981/45/contents
Under this Act, a person commits an offence if they:
Pharmacies are frequently presented with faxed prescriptions, emailed copies, or photos on a patient’s phone. While these may appear convenient, they raise important legal and patient safety issues.
This article explains what is and is not legally valid, and how pharmacists should approach these situations.
Under the Human Medicines Regulations 2012:
https://www.legislation.gov.uk/uksi/2012/1916/contents
Dental prescriptions can create uncertainty in practice, particularly around what dentists are legally allowed to prescribe and what pharmacists can safely supply. This article clarifies the legal position and the key practical rules.
Dentists are recognised as appropriate practitioners under the Human Medicines Regulations 2012:
https://www.legislation.gov.uk/uksi/2012/1916/regulation/214/made
👉 This means:
An accuracy check is a critical step in the dispensing process, ensuring that the medicine supplied matches the prescription exactly. While often viewed as a technical process, it carries significant legal and professional responsibility.
In UK pharmacy practice, accuracy checking is not explicitly defined in legislation, but it is required in practice through legal accountability, professional standards, and patient safety obligations.
There is no explicit reference in primary legislation requiring an “accuracy check” as a defined step.
Clinical checks are a core legal and professional responsibility for pharmacists. They are not optional or purely procedural—they are fundamental to ensuring medicines are supplied safely and appropriately. In UK practice, this duty is underpinned by professional standards from the General Pharmaceutical Council (GPhC), alongside wider legal frameworks governing safe medicines use.
Pharmacists must ensure that any medicine supplied is clinically appropriate for the individual patient. This obligation arises from:
Failure to carry out an adequate clinical check may result in a dispensing error, which can lead to regulatory action, including fitness to practise proceedings.
Dispensing errors and near misses are an inherent risk within pharmacy practice. Managing these incidents appropriately is essential to protect patients, maintain public trust, and comply with legal and professional requirements.
Pharmacists and pharmacy teams must operate within a culture of openness, learning, and continuous improvement, ensuring that errors are addressed promptly and used to strengthen systems of care.
A dispensing error occurs when a medicine is supplied to a patient that is:
Adverse drug reactions (ADRs) are a significant cause of patient harm and represent an important area of professional responsibility for pharmacy teams. In the UK, the reporting of suspected ADRs is primarily carried out through the Yellow Card Scheme, operated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Pharmacists play a key role in identifying, managing, and reporting ADRs to support national pharmacovigilance and patient safety.
Pharmacovigilance in the UK is governed by the
https://www.legislation.gov.uk/uksi/2012/1916/contents
(Human Medicines Regulations 2012).
The growth of online prescribing and distance-selling pharmacy services has introduced significant risks around the safe and appropriate supply of medicines. In response, the General Pharmaceutical Council (GPhC) has strengthened its regulatory expectations for pharmacies operating remotely, particularly where prescribing is carried out online.
Pharmacy owners, superintendent pharmacists, and responsible pharmacists must ensure that any supply made through an online model meets both legal requirements and professional standards.
Registered pharmacies in Great Britain are regulated by the General Pharmaceutical Council under the Pharmacy Order 2010, which gives the GPhC enforcement powers over pharmacy owners, superintendent pharmacists, and pharmacy professionals.
Gonadotrophin-releasing hormone (GnRH) analogues are used in clinical practice to suppress puberty. In the UK, their use in children and young people for gender incongruence or gender dysphoria is subject to specific legal restrictions.
Pharmacists must ensure they understand both the legislative framework and the practical implications for dispensing, particularly where prescriptions originate from private or non-UK prescribers.
The sale and supply of medicines in the UK is governed by the
https://www.legislation.gov.uk/uksi/2012/1916/contents
(Human Medicines Regulations 2012).
New Psychoactive Substances (NPS) are substances designed to produce psychoactive effects similar to controlled drugs but may not initially fall under traditional drug control laws. Their regulation in the UK is primarily governed by the Psychoactive Substances Act 2016.
Under the Psychoactive Substances Act 2016, a psychoactive substance is defined as a substance that:
“is capable of producing a psychoactive effect in a person”